• Explore /
  • Poster
  • / Final results of a phase II trial of prolgolimab with platinum-based therapy and bevacizumab in patients with advanced cervical cancer.

Final results of a phase II trial of prolgolimab with platinum-based therapy and bevacizumab in patients with advanced cervical cancer.

Abstract Poster

Authors

null

Sergey Fogt

Biocad, Saint-Petersburg, Russian Federation

Sergey Fogt , Timur Andabekov , Yana Shamsutdinova , Mikhail Dvorkin , Elena Artamonova , Valerii Chistyakov , Ruslan Zukov , Vladimir Moiseenko , Marina Nechaeva , Svetlana Odintsova , Natalia Fadeeva , Nikolai Kislov , Denis Tantsyrev , Sergei Tjulandin , Eugeniy Fomin , Iuliia Linkova , Arina Zinkina-Orikhan , Mariia Shustova , Lyudmila Zhukova

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Cervical Cancer

Clinical Trial Registration Number

NCT03912402

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 5536)

DOI

10.1200/JCO.2023.41.16_suppl.5536

Abstract #

5536

Poster Bd #

231

Abstract Disclosures

Similar Posters

First Author: Xieqiao Yan

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Phase 1/2 evaluation of revumenib in patients with advanced colorectal cancer and other solid tumors.

Phase 1/2 evaluation of revumenib in patients with advanced colorectal cancer and other solid tumors.

First Author: Aparna Raj Parikh

First Author: Jianqing Zhu

First Author: Jihong Liu